Bond funds on record pace after raking in nearly $400 billion in first half of 2024

by OverviewFX | Jul 8, 2024 | Stocks

Investors are pouring into fixed-income funds as interest-rate cuts by global central banks begin.

I’m 65 and five years away from retiring. Is it worth paying an investment adviser a fee to manage my $1.5 million nest egg?

by OverviewFX | Jul 8, 2024 | Stocks

“They recommend shifting to a 70/30 mix since I plan to work until I’m 70.”

The stock market’s breadth may have already peaked. Here’s why a 20% drawdown could follow.

by OverviewFX | Jul 8, 2024 | Stocks

A few large-cap tech companies continue to drive up the S&P 500, and one strategist believes a significant drawdown for U.S. stocks could be on the way.

UBS leans into Bank of America ahead of micro-focused bank earnings

by OverviewFX | Jul 8, 2024 | Stocks

UBS analysts on Monday called Bank of America the “most interesting money center,” as major banks approach second-quarter earnings season later this week.

Your stocks don’t care about the overall economy. These 2 gauges matter more.

by OverviewFX | Jul 8, 2024 | Stocks

Stock investors emphasize interest-rate trends and investor sentiment.

HilleVax’s stock craters after biotech says it’s scrapping a norovirus vaccine for infants after a failed trial

by OverviewFX | Jul 8, 2024 | Stocks

HilleVax Inc.’s stock cratered 89% early Monday, after the biotech said it would discontinue development of a vaccine against norovirus for infants after a trial missed its main goals.